Advancing Genetic
Diagnostics for
Precise Medicine.

Impact Genetics provides cost-effective, high quality genetic testing for rare diseases.

In collaboration with our leading scientists and clinical care providers, we continually refine tests to maximize sensitivity. New scientific discoveries, genetic data and clinical knowledge flow freely to maximize health impact. Impact Genetics’ service delivery team is committed to supporting doctors and genetic specialists with outstanding service.

  • June 4th, 2014 – NEW TEST FOR UVEAL MELANOMA. Impact has launched a new prognostic test for Uveal Melanoma. This genetic test identifies the risk of metastasis, indicating survival prognosis in patients with Uveal Melanoma.
    More information.

Services

We offer the following clinical genetic tests in our CAP/CLIA certified lab.

Why choose us?
  • Cost effective
  • Documented high diagnostic sensitivity
  • Provided by disease experts
  • Flexible billing and personal support
  • Quick turn-around times
  • Comprehensive and informative reports

More about our services

News and Events
October 16th at 12pm EDT – Retinoblastoma Online Education Webinar, Presented by Dr. Gallie and Impact Genetics. More information and to register.
Impact Genetics has launched a new prognostic test for Uveal Melanoma. More details here.
Impact’s Retinoblastoma Genetic Test now includes the MYCN gene. More details here.

More news and events